Interaction of apolipoprotein AIV with cholecystokinin on the control of food intake

• Published in: American journal of physiology. Regulatory, integrative and comparative physiology Vol. 293; no. 4; pp. R1490 - R1494
• Main Authors: Lo, Chun Min, Zhang, Dian Ming, Pearson, Kevin, Ma, Liyun, Sun, William, Sakai, Randall R, Davidson, W. Sean, Liu, Min, Raybould, Helen E, Woods, Stephen C, Tso, Patrick
• Format: Journal Article
• Language: English
• Published: United States American Physiological Society 01.10.2007
• Subjects: Animals; Antioxidants - metabolism; Antioxidants - pharmacology; Apolipoproteins A - metabolism; Apolipoproteins A - pharmacology; Appetite Depressants - metabolism; Appetite Depressants - pharmacology; Diet; Dose-Response Relationship, Drug; Feeding Behavior - drug effects; Feeding Behavior - physiology; Hormone Antagonists - pharmacology; Intestine, Small - metabolism; Male; Metabolism; Peptides; Proglumide - analogs & derivatives; Proglumide - pharmacology; Proteins; Rats; Rats, Sprague-Dawley; Rodents; Sincalide - metabolism; Sincalide - pharmacology; T cell receptors; Time Factors
• ISSN: 0363-6119; 1522-1490
• DOI: 10.1152/ajpregu.00329.2007

Departments of 1 Pathology and Laboratory Medicine and 2 Psychiatry, University of Cincinnati, Cincinnati, Ohio; 3 Department of Anatomy, Physiology and Cell Biology, School of Veterinary Medicine, University of California, Davis, California; and 4 Laboratory of Experimental Gerontology, National Institute on Aging, Baltimore, Maryland Submitted 10 May 2007 ; accepted in final form 17 July 2007 Apolipoprotein AIV (apo AIV) and cholecystokinin (CCK) are peptides that act both peripherally and centrally to reduce food intake by decreasing meal size. The present study examined the effects of intraperitoneally administered bolus doses of recombinant apo AIV, CCK-8, and a combination of subthreshold doses of apo AIV and CCK on 4-h food intake in rats that were fasted overnight. Apo AIV at 100 µg/kg reduced food intake significantly relative to the saline control for 1 h, as did doses of CCK-8 at or above 0.125 µg/kg. Doses of apo AIV (50 µg/kg) or CCK (0.06 µg/kg) alone had no effect on food intake. However, when these subthreshold doses of apo AIV and CCK were administered together, the combination produced a significant inhibition of food intake relative to saline controls ( P < 0.001), and the duration of the effect was longer than that caused by the administration of either apo AIV or CCK alone. The satiation effect produced by CCK-8 + apo AIV was attenuated by lorglumide, a CCK1 receptor antagonist. We conclude that, whereas the intraperitoneal administration of doses of either recombinant apo AIV or CCK at or above threshold levels reduces food intake, the coadministration of subthreshold doses of the two peptides is highly satiating and works via CCK1 receptor. intraperitoneal injection; inhibition; satiation effect Address for reprint requests and other correspondence: P. Tso, Dept. of Pathology and Laboratory Medicine, Univ. of Cincinnati, 2120 E. Galbraith Rd., Cincinnati, OH 45237-0507 (e-mail: tsopp{at}email.uc.edu )